gadolinium oxide
Drug ingredientCAS 11129-31-0
This chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
US productionNot reported
Top sourceNo public record
This chemical is not on EPA’s Toxic Substances Control Act inventory, the list behind EPA’s production survey.
Why supply is unknownWhere It Comes From
EPA and Census publish no US supply data for this chemical.
1 FDA-registered drug labeler
Energique, Inc.
Why It Matters
Sectors
Health
Downstream Uses
Appears in 1 drug and cosmetic product listings (FDA).
- •Metalstat
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No FDA shortage records
Chemical Identity
CAS11129-31-0
PubChem CID159427
DTXSIDDTXSID00912093
FormulaGd2O3
Mol. Weight362.5 g/mol
SMILES[O-2].[O-2].[O-2].[Gd+3].[Gd+3]
Data Sources
- PubChem · compound 159427Retrieved 2026-04-07
- FDA National Drug Code directoryRetrieved 2026-04-25
- FDA National Drug Code directoryRetrieved 2026-04-07
Brief citations
gadolinium oxide (CAS 11129-31-0) https://chemicalindependence.com/chemical/11129-31-0/ PubChem: 159427. Retrieved 2026-04-07. https://pubchem.ncbi.nlm.nih.gov/compound/159427 FDA National Drug Code directory: CAS 11129-31-0. Retrieved 2026-04-25. https://open.fda.gov/data/ndc/ FDA National Drug Code directory: bulk match. Retrieved 2026-04-07. https://open.fda.gov/data/ndc/